Acute local inflammatory reaction to hylan G-F 20 Synovial fluid anaphylaxis Terminal complement complex s u m m a r y
Introduction
Hylan G-F 20 (Genzyme Biosurgery, Cambridge, MA) is a safe and generally well-tolerated viscosupplementation for intraarticular injections in patients with symptomatic osteoarthritis (OA) 1, 2 as well as after arthroscopic meniscectomy 3 . Severe local flares have been described as rare reactions in patients with bilateral OA and a history of unilateral meniscectomy 4 . While distinctive inflammatory flares were previously described, a clear mechanism responsible for their initiation has yet to be studied in detail 5 . Hylan G-F 20 gains immunogenicity by chemical cross-linked processing that enables it to persist longer when injected in the knee 6 . In addition, in patients who underwent meniscectomy, cytokinedriven synovial inflammation occurs more frequently than in patients with established knee OA 7 . In these patients specifically, the combination of the two may be one of the possible risk factors involved in the pathogenesis of the flare-ups.
In our case report, we provide histological and immunebiochemical evidence to suggest that the local flare is possibly an immune mechanism with features of a reactive-like arthritis with complement activation and production of inflammatory cytokines without ignoring other potentially distinctive mechanisms. To our knowledge, this is the first description of the possible local involvement of the complement pathway in a synovial fluid and tissue immune reaction to hylan G-F 20.
Methods, results and discussion
We present the case of a 55-year-old woman with bilateral OA, who had undergone left knee meniscectomy 9 years previously and received in the last year two 5 ml treatments with hylan G-F 20 in both knees at our hospital. The radiograph diagnosed a severe grade 4 OA in the left knee without evidence of chondrocalcinosis in either knee.
Approximately 12 h after the third injection in both knees the patient presented with local massive swelling accompanied by severe pain limited to the left knee joint. Systemic reactions were not described. Decompression by ultrasound-guided aspiration of the left knee joint was performed in the next 12 h yielding 65 ml of yellowish synovial fluid filled with inflammatory cells (WBC 33,950/ mm 3 , RBC 1500/mm 3 , neutrophils 60%, eosinophils 18%, monocytes 19% and lymphocytes 3%). The swelling and pain returned rapidly to the previous state and an emergency arthroscopic irrigation and debridement were performed the following day. Synovial fluid and tissue were collected for further processing. The blood reports indicated acute phase reactants with slightly elevated ESR at 33 mm/ h (Westergren method, normal values ¼ 0e27 mm/h) and high Creactive protein (CRP) at 6.4 mg/dl (normal values range from 0 to 1 mg/dl). Microscopic examination of freshly prepared synovial fluid for crystal deposits, Gram's stain, and cultures of the synovial fluid were all negative. The treatment included oral ciprofloxacin for 7 days and non-steroidal anti-inflammatory drugs, analgesics, and rest. During the arthroscopic debridement, synovial exudate and tissue were obtained and placed in 15 ml of Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) for explant culture at 37 C. After a week, the primary synovial culture revealed a mixed population with 35% representing macrophages containing microvesicles with hylan G-F 20 [50Â magnification; Fig. 1(A (i) ) and 200Â magnification; Fig. 1(A (ii)) ]. In addition, 5-mm thin formalin-fixed paraffin embedded sections of exudate and tissue obtained during arthroscopy were stained with hematoxylin and eosin (H&E; SigmaeAldrich, St. Louis, MO), and antibodies against CD3/CD5 for T-cells, CD20 for B-cells, CD117 for mast cells, and CD68 for macrophages (all from Esoterix Genetic Laboratories, NY, NY, USA), as well as anti-C5b-9 (Antibody Shop, Denmark). Images viewed by ImageJ served to count the cells and evaluate the percentage differences between primary and immune cells, as described by Girish et al. 8 . The histological pattern of the acute reaction to hylan G-F 20 described previously is of a peculiar granulomatous reaction, with palisading macrophages around hyaluronan particles and multinucleated giant cells 9 . In contrast, as seen in Fig. 1 (B (i) and (ii)), the fibrinous exudate from the case patient joint contained numerous fragments of non-birefringent amorphous material (hylan G- ] were also present. The predominant presence of macrophages (34%) and T lymphocytes (29%) with only 2% B lymphocytes and 1.5% mast cells in the inflammatory infiltrate, while suggestive of an immune mechanism mediated by these cells, is only partially similar to that identified in rheumatoid arthritis (RA)-like inflammatory arthritis 10 , where B lymphocytes generally presenting in significant number play a major role. During the arthroscopic debridement, synovial fluid was obtained for further studies of immune-driven acute joint inflammation. In addition to our case patient, we utilized three representative RA and three OA patients to address the comparison with positive and negative controls. The patients, the majority of whom were the same gender as our patient and of ages ranging from 40 to 78 years, signed an informed consent and the necessary synovial samples were obtained with the approval of the Hospital for Special Surgery (HSS) Institutional Review Board. The study focused further on local activation of the complement pathway, specifically C5a and C5b-9, which are well-described players in the development of synovitis in immune arthritides. Previous reports have suggested that C5a and C5b-9 concentrations are elevated in RA joints relative to OA joints 11e13 as well as the central role of C5b-9 in crystalinduced arthropathies 14 . Enzyme-linked immunosorbent assays (ELISAs) for markers of complement activation and cytokines were performed. The concentrations of interleukin-1 beta (IL-1b), C5a and C5b-9 in synovial fluid were determined using commercially available ELISAs (IL-1b and C5b-9: BD Biosciences, Franklin Lakes, NJ; C5a: R&D Systems, Minneapolis, MN), according to the manufacturers' instructions. Our experimental results demonstrate that the concentrations of IL-1b in the case patient (210 pg/ml) were nine times higher than in RA patients (25 pg/ml) and 100 times higher than in OA patients (2 pg/ml) [ Fig. 2(A (i) )]. The complement fragment C5a concentration was 9 ng/ml, closer to the average concentration of 10 ng/ml in the synovial fluids of the three RA patients, but almost four times higher than the average concentration of 2.5 ng/ml in the three OA patients [ Fig. 2(A (ii) )]. The concentration of the C5b-9 complex was highest in our case patient at 5500 ng/ml, compared to the average concentrations in synovial fluids of 4500 ng/ml in the RA patients and 800 ng/ml in the OA patients [ Fig. 2(A (iii) )]. Therefore, we hypothesize that the local immune profile changed in the patient from a low inflammatory response characteristic of OA to a highly inflammatory arthritis pattern with a predominant synovial T lymphocytic infiltrate [ Fig. 1(C (i) )], alongside a neutrophilic and eosinophilic infiltration in the synovial exudate around hylan G-F 20 particles [ Fig. 1 (B (i) and (ii))]. This immunological response is interpreted in a large part to be secondary to the activation of the complement pathway, since the lymphocytic infiltrate observed in OA is usually perivascular and of mixed B and T cell pattern, with scattered presence of mast cells. The numerous macrophagic component is considered secondary to OA and also to the hylan deposits [ Fig. 1(B (iv) and C (iv))].
The presence of C5b-9 deposits in synovial tissue correlates well with the presence and extent of inflammatory synovitis in OA and RA 11 . In the case patient, we observed diffuse presence of stained C5b-9 deposits intermixed with inflammatory cells in the fibrinous exudate and vascular endothelial cells with a membranous pattern [ Fig. 2(B (iii) and (iv) )]. RA patients showed a similar distribution [ Fig. 2(B (ii) )], whereas in OA patients there were not any deposits [ Fig. 2(B (i)) ]. Three marker genes with major roles in local joint inflammation, IL-1b, IL-6 and a neutrophil marker myeloperoxidase (MPO), were also analyzed by quantitative realtime polymerase chain reaction (RT-PCR) in synovial tissues of the case patient alongside the three OA and three RA patients [ Fig. 2(C(i)e(iii) )]. The presence of numerous neutrophils in the inflamed knee joint may contribute greatly in our case patient to local flare, and the production of abundant cytokines such as IL-1b and IL-6 and specific enzymes such as MPO 15 . IL-1b and IL-6 are major inflammatory cytokines expressed in synovium in RA 16 , but at lower levels in OA patients 17 . In our patient synovium, IL-1b mRNA was 34-fold higher compared to OA patient samples and 15-fold higher than in synovium from RA patients [ Fig. 2(C (i)) ]. In addition, the IL-6 mRNA levels were similar to those for IL-1b and 36-fold and 16-fold higher than those in the OA and RA patients respectively [ Fig. 2(C (ii) )]. MPO gene expression was five times higher in the patient injected with hylan G-F 20 than in the RA and OA patients [ Fig. 2(C (iii))] ; however, the patients in the RA and OA groups demonstrated little elevation. This might be a direct result of the high number of neutrophils present in the synovium of the case patient and a less severe OA phenotype because MPO is considered a possible marker of early OA 15 . There are several possibilities explaining the immunological profile of the case patient. First, the reaction indicated similarities with flares in crystal-induced arthropathies associated with cell surface cleavage of C5 and formation of the complement attack complex (C5b-9) 14 while the phagocytosis of hylan G-F 20 by macrophages triggered the NLRP3 inflammasome activation with release of inflammatory mediators and influx of neutrophils in the joint 18 . Second, an alternative hypothesis of previous sensitization 5 via deposits of hylan G-F 20 is worthy of consideration. We have recently observed a case of total knee replacement in a female patient also affected by grade 4 OA. In addition of numerous eosinophils and scattered neutrophils [ Fig. 1 (D (i) and (ii))], deposits of hylan with palisading macrophages and giant cells and scattered lymphocytes were equally present in the bone marrow and synovium. However, to make conclusions about a comparable process, more studies of the acute flare reactions in similar patients are necessary. Third, in this study we have presented similarities with inflammatory arthropathies such as reactive arthritis and RA illustrated by the presence of numerous T lymphocytes and macrophages, complement activation, and release of specific proinflammatory cytokines. Nevertheless, this association might not be ideal when the cellular composition of the immune infiltrate, almost virtual absence of CD20þ and CD38þ cells and the presence of eosinophils, is carefully examined.
While severe, the inflammatory knee changes were only temporarily present. Benefiting from rehabilitation therapy, by 6 months, the knee functionality was fully recovered, and at 1 year, the same performance level was observed as before the acute reaction occurred.
In this study we cannot assess why the flare did not occur in the contralateral joint or at other times during the treatment regimen. The severity of OA, the prolonged presence of the foreign substance in the synovium and the accumulation exceeding a certain threshold may be contributing factors to a local sensitization in certain susceptible individuals. Additional studies of the acute flare reaction in patients with multiple treatments of viscosupplementation are warranted.
